Foghorn Therapeutics Inc.
FHTX
$4.88
-$0.18-3.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 158.89M | 180.28M | 198.67M | 220.59M | 243.75M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.09M | 2.59M | 3.93M | 4.83M | 5.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.25M | 1.25M | 1.25M | -- | -- |
| Total Current Assets | 163.24M | 184.12M | 203.84M | 225.42M | 249.60M |
|
|
|||||
| Total Current Assets | 163.24M | 184.12M | 203.84M | 225.42M | 249.60M |
| Net Property, Plant & Equipment | 32.86M | 18.84M | 20.39M | 31.54M | 32.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.00M | 2.01M | 2.01M | 1.73M | 1.78M |
| Total Assets | 198.10M | 204.96M | 226.24M | 258.69M | 283.98M |
|
|
|||||
| Total Accounts Payable | 4.27M | 3.21M | 3.32M | 4.07M | 3.79M |
| Total Accrued Expenses | 11.36M | 9.82M | 8.56M | 6.45M | 8.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 923.00K | 6.76M | 6.18M | 9.11M | 9.07M |
| Total Finance Division Other Current Liabilities | 43.19M | 65.30M | 59.72M | 51.67M | 45.61M |
| Total Other Current Liabilities | 43.19M | 65.30M | 59.72M | 51.67M | 45.61M |
| Total Current Liabilities | 59.74M | 85.09M | 77.79M | 71.31M | 66.99M |
|
|
|||||
| Total Current Liabilities | 59.74M | 85.09M | 77.79M | 71.31M | 66.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 40.35M | 15.77M | 17.52M | 25.74M | 28.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 206.52M | 193.76M | 207.59M | 223.30M | 234.46M |
| Total Liabilities | 306.60M | 294.62M | 302.90M | 320.34M | 329.51M |
|
|
|||||
| Common Stock & APIC | 523.94M | 521.12M | 518.34M | 515.35M | 512.52M |
| Retained Earnings | -632.47M | -610.80M | -594.95M | -577.02M | -558.18M |
| Treasury Stock & Other | 24.00K | 24.00K | -44.00K | 14.00K | 135.00K |
| Total Common Equity | -108.50M | -89.66M | -76.66M | -61.65M | -45.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -108.50M | -89.66M | -76.66M | -61.65M | -45.53M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -108.50M | -89.66M | -76.66M | -61.65M | -45.53M |
|
|
|||||